SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001884552-23-000002
Filing Date
2023-02-14
Accepted
2023-02-14 12:39:36
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G schedule13G.htm SC 13G 104515
  Complete submission text file 0001884552-23-000002.txt   106141
Mailing Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122
Business Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122 650-800-3717
REVELATION BIOSCIENCES, INC. (Subject) CIK: 0001810560 (see all company filings)

IRS No.: 843898466 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91762 | Film No.: 23625736
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2-4 RUE EUGENE RUPPERT LUXEMBOURG N4 L-2453
Business Address 2-4 RUE EUGENE RUPPERT LUXEMBOURG N4 L-2453 352 621 233 175
AXA IM Prime Impact Master Fund I SCA SICAV-RAIF (Filed by) CIK: 0001884552 (see all company filings)

IRS No.: 000000000 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: SC 13G